In light of concerns related to potential endocrine-disrupting properties of Benzyl Salicylate and Triphenyl Phosphate, the Commission launched a public call for data in 2019 and 2021, respectively. The cosmetics industry submitted scientific evidence to demonstrate the safety of those substances when used in cosmetic products. The Commission requested the Scientific Committee on Consumer Safety (SCCS) to carry out safety assessments of those substances in view of the information provided by industry.
Recital 3, Regulation (EU) 2026/909
In forcesince 27 Apr 2026